Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Lupin to promote Zymar to U.S. pediatricians

April 2, 2004

ThromboGenics and NuVue collaborate on plasmin products for visual disorders

March 16, 2004

Iquix receives FDA approval for bacterial corneal ulcer

March 15, 2004

VEGF Trap enters clinical development program

March 12, 2004

Positive results from Xibrom phase III studies

March 11, 2004

Additional phase III data in support of TTFC

March 10, 2004

Alrex safe for long-term treatment of seasonal allergic conjunctivitis

Feb. 24, 2004

Senju claims new chymase and/or tryptase inhibitors and their use

Feb. 11, 2004

Extension to Vitrase NDA review

Feb. 10, 2004

Inspire to conduct additional trial for diquafosol following FDA meeting

Feb. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...